Literature DB >> 16762157

Leishmania in SLE mimicking an exacerbation.

A Ossandon1, D Bompane, C Alessandri, E Marocchi, F Conti, G Valesini.   

Abstract

Systemic lupus erythematosus is a protean disease which may present manifestations that resemble other diseases posing serious problems of differential diagnosis. Visceral leishmaniasis is a parasitic infection, endemic in 88 countries, whose hallmarks may mimic a lupus flare. Fever, pancytopenia, splenomegaly, hypergammaglobulinemia, production of autoantibodies and complement consumption are some of the overlapping features between the two diseases. Thus, extra attention must be paid to patients with lupus who present with the mentioned symptoms. Diagnosis of visceral leishmaniasis relies on the detection of leishmania antibodies, on the presence of amastigotes in bone marrow aspirates, biopsies and cultures of the parasite. Treatment is based on the use of i.v. liposomal amphotericin B. The missed recognition of a leishmania infection in a lupus patient may lead to death, since both the omission of a specific anti-parasite treatment and the increase of the immunosuppressive therapy, in the conviction of a lupus flare, accelerate a fatal outcome. In this paper we present a case of visceral leishmaniasis occurring in a lupus patient. The clinical and laboratory features that overlap in the two diseases and the current literature on the topic were discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762157

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  2 in total

1.  Visceral leishmaniasis, systemic lupus erythematosus and acute hepatitis.

Authors:  Annalisa Celant; Guido Chichino; Barbara Dal Bello; Marco Massarotti; Lorenzo Minoli; Bianca Marasini
Journal:  Rheumatol Int       Date:  2008-05-24       Impact factor: 2.631

2.  [Pericardial tamponade revealing systemic lupus erythematosus during the course of atypical visceral leishmaniasis].

Authors:  Hajer Ben Brahim; Maha Ben Nasr; Hela Boussaid; Ikbel Kooli; Abir Aouam; Adnene Toumi; Chawki Loussaief; Mohamed Chakroun
Journal:  Pan Afr Med J       Date:  2014-08-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.